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Abstract 
AIM: To compare the glycaemic and metabolic responses to simulated intermittent games 
activity and continuous running exercise in T1DM. METHODS: Nine patients (7 male, 2 
female; 354 years; HbA1c 8.10.2% / 652 mmol.mol-1) treated on a basal-bolus regimen 
completed two main trials, a continuous treadmill run (CON) or an intermittent running protocol 
(INT). Patients arrived to the laboratory fasted at ~08:00 h, replicating their usual pre-exercise 
meal and administering a 50% reduced dose of rapid-acting insulin before exercising. Blood 
glucose (BG), K
+
, Na
++
, pH, triglycerides, serum cortisol and NEFA were measured at baseline 
and for 60 minutes post-exercise. Interstitial glucose was measured for a further 23 hours under 
free-living conditions. RESULTS: Following exercise, BG declined under both conditions but 
was less under INT (INT -1.1±1.4 vs. CON -5.3±0.4 mmol.l
-1
, p=0.037) meaning more patients 
experienced hypoglycaemia (BG≤3.5mmol.l-1; CON n=3 vs. INT n=2) but less hyperglycaemia 
(BG≥10.9 mmol.l-1; CON n=0 vs. INT n=6) under CON. Blood lactate was significantly greater, 
and pH lower, with a temporal delay in K
+
 under INT (p<0.05). No conditional differences were 
observed in other measures during this time, or in interstitial glucose concentrations during the 
remaining 23 hours after exercise. CONCLUSIONS: Simulated games activity carries a lower 
risk of early, but not late-onset hypoglycaemia than continuous running exercise in T1DM. 
 
 
 
 
 
Introduction 
Despite recommendations from the American College of Sports Medicine (2009), performance 
of continuous or prolonged aerobic based exercise carries with it a heightened risk of 
hypoglycaemia in patients with type 1 diabetes (T1DM) (Rabasa-Lhoret et al. 2001; West et al. 
2010; Campbell et al. 2013). This not only has potentially dangerous implications (Brazeau et al. 
2008), but also discourages individuals wishing to exercise (Brazeau et al. 2008) and reduces 
long-term adherence to exercise programs that might convey health benefits (Perkins and Riddell 
2006). 
Not all forms of exercise acutely lower blood glucose however, meaning some types of exercise 
carry a lower risk of hypoglycaemia (Fahey et al. 2012). High-intensity exercise often causes an 
acute increase in blood glucose concentrations in patients with T1DM (Marliss and Vranic 2002; 
Fahey et al. 2012), and the inclusion of this type of activity in an intermittent form (i.e. short 
bursts of high intensity exercise interspersed with moderate intensity aerobic exercise) has been 
demonstrated to abate the risk of hypoglycaemia early after exercise (Guelfi et al. 2005; Bussau 
et al. 2006; Bussau et al. 2007; Guelfi et al. 2007).  
From a practical perspective, much of the work in this area was designed to simulate the 
demands of team games such as soccer, rugby and hockey by creating exercise patterns in 
controlled laboratory environments (Guelfi et al. 2005; Bussau et al. 2006; Bussau et al. 2007; 
Guelfi et al. 2007; Iscoe and Riddell 2011). A major limitation of much of this research is the 
predominant use of cycling as an exercise modality (Guelfi et al. 2005; Bussau et al. 2006; 
Bussau et al. 2007; Guelfi et al. 2007; Iscoe and Riddell 2011). Cycling fails to adequately 
replicate the physiological demands of games-type activities in which repeated changes in speed 
and direction are a major component. Cycling involves primarily concentric muscle actions 
(Bijker et al. 2002) meaning the muscle shortens as it contracts, whereas in the majority of 
intermittent game-type activities, which typically involve running, a significant proportion of 
eccentric muscle action occurs, where the muscle lengthens during contraction. This is a 
particularly important consideration for individuals with T1DM, as eccentric muscle actions have 
the potential to hinder insulin action and glucose uptake following exercise (Asp et al. 1995). In 
addition, eccentric-based intermittent shuttle-running exercises which incorporate vast changes 
in speed and direction have been demonstrated to induce severe muscle soreness and muscular 
dysfunction (Bailey et al. 2007). Indeed, sprinting exercise has previously been observed as a 
primary mechanism of injury (Hawkins et al. 2001; Woods et al. 2004); the frequency of speed 
changes places greater emphasis on the acceleration and deceleration phases of the running 
cycle, thus applying more eccentric load than conventional cycling based sprinting protocols 
(Greig and Siegler 2009). 
Furthermore, the observation window in many studies investigating intermittent exercise is 
typically short (< 3 hours) (Guelfi et al. 2007; Harmer et al. 2007). A recent study conducted by 
Iscoe and Riddell (Iscoe and Riddell 2011) demonstrated that intermittent cycling exercise was 
associated with a reduction in late onset post-exercise hypoglycaemia. However, in light of the 
afore limitations, the glycaemic and metabolic demands of intermittent cycling exercise may not 
be directly transferable to games-like activities, thus limiting the application of current research 
investigating intermittent exercise. 
Clearly, the inclusion of intermittent exercise has favorable effects for reducing the occurrence of 
hypoglycaemia. However, many investigations demonstrating a preservation of glycaemia and a 
reduced risk of hypoglycaemia are often compromised by poor ecological validity. Therefore, it 
would be prudent to measure the glycaemic and metabolic effects of intermittent running early, 
and also late after exercise. Therefore the aim of the present study was to examine and compare 
the acute and 24 hour post-exercise glycaemic and metabolic responses to intermittent running 
exercise which closely simulates team and games-play activity, and continuous moderate-
intensity exercise, in type 1 diabetes patients. 
Materials and methods 
Following local research ethics committee approval, nine T1DM patients (seven males and two 
females, [mean±SEM] age 35 ± 4 years, mass 84.1 ± 3.9 kg, height 177 ± 3 cm, BMI 26.8 ± 1.1 
kg.m
-2
, HbA1c 8.1 ± 0.2 % / 64.8 ± 2.3 mmol.l
-1
, VO2peak 41.8 ± 1.6 ml.kg
-1
.min
-1
) were recruited 
to participate in this study. Patients were eligible if treated on a basal bolus regimen composed of 
slow-acting insulin glargine (n=8) or detemir (n=1), and fast-acting insulin analogues aspart (n = 
7) or lispro (n = 2) for a minimum of 6 months, with a duration of diabetes >2 years on 
enrollment. Patients were habitually active and regularly exercising (3 times per week for 30 
minutes or more), familiar with carbohydrate counting, free of any diabetes related 
complications, and not receiving any other medication other than insulin (both females were 
taking progesterone only oral contraception). 
Having provided full written informed consent, patients attended two preliminary laboratory 
visits before completing 2 main trials, a continuous treadmill run (CON), or an intermittent 
running protocol (INT). On visit 1, peak cardiorespiratory parameters were collected during the 
completion of an incremental-maximal treadmill run protocol. This was used to determine the 
speed to be undertaken by patients during CON. The treadmill exercise test started at a velocity 
of 8 km.hr
-1
 increasing 1 km.hr
-1
 every three minutes as described previously (West et al. 2010; 
West et al. 2011; Campbell et al. 2013). During this visit, anthropometric variables were also 
collected (stature, weight, BMI). Following this, patients returned to the laboratory to complete a 
multistage fitness test (MSFT), as per Ramsbottom et al (1988). The performance during this test 
was used to calculate appropriate running speeds for INT. During this visit, patients completed 
30 minutes of the intermittent exercise protocol for familiarization. Visits 3 and 4 were 
experimental trials (INT or CON) conducted in a random and counter-balanced fashion.  
Prior to their arrival to the laboratory for each main trial, patients were fitted with a continuous 
glucose monitoring system (CGMS® System Gold™, Medtronic Minimed, Northridge, CA, 
USA). Interstitial glucose concentrations were obtained for 23 hours following their discharge 
from the laboratory, and during this time patients were instructed to adhere to similar diets. Both 
main trials were conducted on a morning ~08:00 h with patients replicating their trial start time. 
Patients arrived to the laboratory having fasted overnight replicating their dietary intake 
(assessed using weighed dietary recording sheets) in the previous 24 hours. Additionally, patients 
were instructed to maintain their normal insulin regimen with basal insulin dose (dose, injection 
site, and time of injection) standardised across trials. Patients were required to abstain from 
exercise during the preceding 48 hours and maintain similar activity patterns between trials. 
Upon arrival, patients replicated their usual pre-exercise meal, and administered a 50% reduction 
in their typical rapid-acting insulin dose (1.6 ± 1.2 IU). Following this, patients were seated 
whilst a 21-gauge cannula (Vasofix; B.Braun Melsungen AG, Melsungen, Germany) was 
inserted into the anti-cubital vein of their non-dominant arm. The trials began when participants 
displayed BG values in the range of 7-12 mmol.l
-1 
(Perry and Gallen 2009). Following a pre-
exercise resting venous blood sample (10 ml), patients performed either the CON or INT 
exercise protocol, with subsequent blood samples at 0, 5, 15, 30 and 60 minutes post-exercise. 
Blood samples were collected in serum separation tubes, with 300 μl removed for the immediate 
quantification of blood glucose, lactate, potassium (K
+
), sodium (Na
++
)  as well as hematocrit 
(GEM premier 3000; Instrumentation laboratory, Werfen Group, Spain), and hemoglobin 
(Hemocue AB, Sweden) which were used to correct for changes in plasma volume changes (Dill 
and Costill 1974). An aliquot of 1 ml was placed on ice and measured for blood pH. The 
remaining sample was centrifuged for 15 minutes at 3000 rev.min
-1
 before being stored at -80˚C 
for the subsequent analysis of cortisol (Cortisol, Cobas-Roche, UK), triglycerides (Triglycerides 
GPO-PAP, Cobas-Roche, UK), and NEFA (NEFA-HR(2), Wako Chemicals, Germany).  
The CON exercise protocol consisted of a 45 minute bout of treadmill running (Woodway, 
Germany) at 77.0 ± 2.5% VO2peak, 8.3 ± 0.6 km.hr
-1
. The INT exercise protocol consisted of 
patients performing 45 minutes of an intermittent running protocol (Loughborough Intermittent 
Shuttle Test; (Nicholas et al. 2000)) designed to simulate games play activity. During both 
exercise protocols breath-by-breath respiratory parameters (Metamax 3B; cortex, Germany) and 
heart rate (S810; Polar, Finland) were recorded continuously throughout. Hypoglycaemia was 
defined as a blood glucose concentration of ≤ 3.5 mmol.l-1 and hyperglycaemia ≥ 10.9 mmol.l-1 
(Yardley et al. 2012). If patients experienced hypoglycaemia during their laboratory stay, a 20 g 
carbohydrate bolus was administered (Lucozade; GlaxoSmithKline, UK). 
Statistical analysis was performed using SPSS software (version 13; SPSS Inc; USA). Data is 
presented as mean ± SEM, with statistical significance set at p < 0.05. A repeated-measures 
ANOVA on two levels (condition x time) was conducted, with Bonferroni-corrected pairwise 
comparisons and paired samples Student t tests used to examine time and condition effects, 
respectively. 
Results 
On the day of the trial, dietary patterns were similar, with no differences in total energy intake 
(CON 2249  110 vs. INT 2130  128 kcal, p = 0.750), with percentage contribution from 
carbohydrate (CON 53  3.3 vs. INT 54  3.9 %, p = 0.619), fat (CON 29  2.8 vs. INT 31  
3.6 %, p = 0.401), and protein (CON 17.5  1.8 vs. INT 14.5  1.3 %, p = 0.167), similar 
between conditions. 
The blood glucose responses are presented in Figure 1. There was a significant time effect (p 
<0.001, partial-η2 = 0.559) and a significant condition X time interaction (p = 0.004, partial-η2 = 
0.375) for absolute blood glucose concentrations. Fasting and rested blood glucose was similar 
between conditions (CON 10.6 ± 0.9 vs. INT 11.2 ± 0.7 mmol.l
-1
, p = 0.648). Exercise induced a 
drop in blood glucose from resting concentrations under both CON and INT (Figure 1). The 
decline in blood glucose following exercise was significantly less under INT, (INT -1.1 ± 1.4 vs. 
CON -5.3 ± 0.4 mmol.l
-1
, p = 0.037), despite patients exercising at a similar %VO2peak (CON 
77.0 ± 2.5 vs. INT 77.6 ± 4.6 %VO2peak, p = 0.829) and HR (CON 157 ± 4 vs. INT 159 ± 2 
bpm). During the post-exercise period, blood glucose AUC was on average greater, but not 
significant, under INT (INT 1604 ± 74 vs. CON 1093 ± 54 mmol.l
-1
.min
-1
, p = 0.112). 
Resultantly, more patients under CON experienced hypoglycaemia (blood glucose ≤ 3.5mmol.l-
1
; CON n = 3 vs. INT n = 2). Inversely, fewer patients under CON experienced hyperglycaemia 
(blood glucose ≥ 10.9 mmol.l-1; CON n = 0 vs. INT n = 6). 
Blood lactate was significantly higher under INT for 60 minutes post-exercise (Figure 2; Table 
1). Blood pH concentrations were significantly lower under INT for 30 minutes post-exercise 
(Table 1). The serum cortisol, triglycerides, NEFA, blood potassium and sodium responses are 
presented in table 1.  
No conditional differences were observed in interstitial glucose concentrations during the 
remaining 23 hours after exercise, with mean interstitial glucose (CON 9.1 ± 0.8 vs. INT 8.6 ± 
0.6 mmol.l
-1
, p = 0.715), and total average time spent in hypoglycaemic (CON 157 ± 59 vs. INT 
223 ± 55 mins, p = 0.808) and hyperglycaemic ranges (CON 693 ± 140 vs. INT 684 ± 93 mins, 
p = 0.982) similar between conditions. Additionally, no conditional differences were observed 
between the average maximum (CON 15.7 ± 1.3 vs. INT 17.1 ± 0.8 mmol.l
-1
, p = 0.674) or 
minimum interstitial glucose concentrations (CON 3.2 ± 0.4 vs. INT 2.6 ± 0.1 mmol.l
-1
, p = 
0.729) or the total number of patients experiencing hypoglycaemia INT (n = 6) compared to 
CON (n = 6). 
 
***INSERT FIGURE 1*** 
 
***INSERT FIGURE 2*** 
 
***INSERT TABLE 1*** 
 
 
Discussion 
This study demonstrates for the first time that intermittent running exercise designed to closely 
simulate team and games-play activity, carries a lower risk of early post-exercise hypoglycaemia 
than continuous moderate-intensity exercise in individuals with type 1 diabetes. Beyond this time 
however, patients, under free-living conditions, remain at risk from hypoglycaemia irrelevant of 
exercise modality. 
Both types of exercise were performed at a similar intensity, which was largely aerobic (CON 
77.0 ± 2.5 vs. INT 77.6 ± 4.6 %VO2peak), and with no incidences of hypoglycaemia during either 
condition. Despite this, the fall in blood glucose immediately following exercise was 
significantly less under INT, measured as a change from rest, with a greater preservation of 
glycaemia for 60 minutes post-exercise under this condition. As such, all patients were protected 
from hypoglycaemia for up to 1 hour post-exercise under INT. Conversely, blood glucose under 
CON tended to be lower and resulted in 66% of patients experiencing at least one 
hypoglycaemic episode during this time.  
Intermittent exercise consists of repeated bouts of intense activity (> 80% of VO2peak) 
interspersed with periods of rest or moderate-intensity exercise. During intense activity there is a 
marked increase in catecholamine release (Purdon et al. 1993; Sigal et al. 1994; Guelfi et al. 
2005; Bussau et al. 2006; Guelfi et al. 2007), which mediates a pronounced increase in glucose 
production (Marliss and Vranic 2002) largely through stimulation of muscle glycogenolysis 
(Purdon et al. 1993; Sigal et al. 1994). Importantly, the metabolic responses during each intense 
bout are additive when recovery intervals are short (Bogardus et al. 1981), meaning that in the 
present study there would likely be insufficient time for full clearance of catecholamines from 
the circulation which have a half-life of ~2-3 minutes in plasma (Goldstein et al. 2003). In 
contrast, moderate-intensity exercise achieves only modest increases in catecholamine 
concentrations in healthy and T1DM individuals (West et al. 2011). Resultantly, the deficit 
between glucose uptake and glucose production is much narrower during intense exercise, 
meaning there is generally a lower rate of net glucose loss from the circulation during 
intermittent exercise compared to continuous moderate-intensity exercise. Indeed it is this which 
makes intermittent exercise an attractive strategy for preventing hypoglycaemia in T1DM 
patients. Although we did not measure catecholamines during this study, responses to high-
intensity exercise are known to be comparable (Purdon et al. 1993; Sigal et al. 1999) or slightly 
attenuated (Purdon et al. 1993; Sigal et al. 1994) in individuals with T1DM. Moreover, cortisol 
another counter-regulatory hormone was significantly elevated from rest for 60 minutes post 
exercise under INT. If patients experienced similar increases in catecholamines, this would offer 
a likely explanation towards the attenuation in the decline in blood glucose over the 1 hour post-
exercise period under INT and the avoidance of hypoglycaemia under this condition (Yuen et al. 
2013). In addition, a recent study by Adolfsson and colleagues (2012) demonstrated that growth 
hormone was 2.5-fold higher during, and 10-fold higher 30 minutes after intermittent exercise 
than responses to endurance exercise in T1DM patients. It is possible that growth hormone (GH) 
secretion differed between both conditions, and may have potentiated the preservation of 
glycaemia under INT (Yuen et al. 2013). 
In our study blood lactate concentrations were 10-fold greater under INT following the cessation 
of exercise, and remained significantly elevated from baseline for 60 minutes post-exercise. It 
has previously been demonstrated that intermittent cycling increases blood lactate levels during 
and up to 40 minutes after exercise in individuals with type 1 diabetes (Purdon et al. 1993; Sigal 
et al. 1994; Bussau et al. 2006; Bussau et al. 2007; Guelfi et al. 2007). Although we are unaware 
of published data describing blood lactate responses to intermittent running exercise in this 
patient cohort, similar intermittent shuttle running protocols performed in healthy non-diabetic 
individuals demonstrate an 8-fold increase in blood lactate concentrations post-exercise 
(Nicholas et al. 2000). Because elevated lactate levels could serve to increase gluconeogenesis 
(Consoli et al. 1990; Bussau et al. 2007), we postulate that elevations in lactate concentrations 
could be a contributing factor to the attenuated decline in glucose during the 60 minutes post-
exercise as it is likely catecholamine concentrations would have returned to baseline after ~20 
minutes (Marliss and Vranic 2002). 
Whatever the exact mechanism(s) behind our findings, our results indicate intermittent running 
exercise carries a lower risk of early-onset hypoglycaemia than continuous moderate-intensity 
exercise. In comparison to cycling exercise models (Guelfi et al. 2005; Iscoe et al. 2006; Guelfi 
et al. 2007), the decline in blood glucose following intermittent running exercise was less 
pronounced in our study than previously reported following cycling based protocols (Guelfi et al. 
2005; Iscoe et al. 2006; Guelfi et al. 2007). This is an important finding that has not been 
demonstrated previously and suggests that patients engaging in games-type activity may be at a 
lower risk of early-onset hypoglycaemia than following laboratory-based intermittent cycling.  
Increases in lactate concentrations indicate that the exercised muscle is unable to oxidize all of 
the pyruvate generated by glycolysis via the tricarboxylic acid cycle (Marliss and Vranic 2002). 
As pH is negatively related to lactate concentrations (Richardson et al. 1998), it is unsurprising 
that patients under INT experienced an increase in acidity (pH significantly lower under INT, p 
<0.05); this was accompanied by increased blood K
+
 concentrations immediately following 
exercise, resulting from skeletal Na
++
- K
+ 
pump mechanisms. Importantly, shortly following 
exercise we witnessed a significant conditional drop in K
+ 
under INT. In addition, the temporal 
restoration of K
+ 
was not complete until 60 minutes post-exercise under INT. This is likely due 
to an increase in sensitivity of the Na
++
- K
+ 
pump to intracellular Na
++
,
 
as in our study Na
++ 
was 
unchanged between conditions. 
The finding that there is a temporal delay in the restoration of K
+ 
concentrations following 
intermittent running exercise is particularly important. In the short period following intense 
exercise (generally termed the vulnerable period) individuals may be at a greater risk of cardiac 
arrhythmias and grand-mal seizures, in which hypokalemia (2.5 – 3.0 mmol.l-1) causes 
hyperpolarization in the myocytes’ resting membrane potential and delayed ventricular 
repolarization which can provoke cardiac arrhythmias (Young et al. 1992). Although we 
witnessed only modest changes in blood acidity and K
+
,
 
concentrations
 
remained greater than 
that deemed hypokalemic (< 3.6 mmol.l
-1
; (Gennari 1998)), one must be circumspect when 
extrapolating these findings across different studies, and  to a larger number of individuals, who 
may be less fit, at a greater risk of diabetes complications and predisposed to cardiac 
arrhythmias; HbA1c, hypertension, distal symmetrical polyneuropathy, retinopathy, and exposure 
to hyperglycaemia have all been shown to be risk factors for developing abnormalities in cardiac 
function (Vinik and Ziegler 2007). In addition, elevations in K
+ 
may be further exacerbated by 
medications such as ACE inhibitors and some diuretics which are known to increase serum K
+ 
and are commonly prescribed to T1DM patients.
  
Thus, some patients may experience a greater 
exchange of potassium and may be more susceptible to cardiac arrhythmias following 
intermittent running-based exercise. 
Once patients left the laboratory at 1 hour post-exercise, glycaemia was measured for a further 
23 hours under free-living conditions. Our results revealed that patients under both conditions 
experienced hypoglycaemia during this period. With 67% of patients in hypoglycaemic ranges 
across trials one form of exercise was no less of a risk than another. Previous work from our 
group has demonstrated that there is a need to reduce post-exercise rapid-acting insulin dose 
following continuous moderate-intensity exercise so that glycaemia is preserved and 
hypoglycaemia prevented for up to 8 hours post-exercise (Campbell et al. 2013). We postulated 
that the increased uptake of blood glucose during that study was due to patients administering a 
second full or unchanged dose of insulin during the evening. With this in mind, it may be 
necessary for patients performing intermittent running exercise to reduce their post-exercise 
rapid-acting insulin dose. However, dose adjustments are yet to be determined for this exercise 
modality. 
Perspective 
This is the first study to investigate the glycaemic and metabolic responses of intermittent 
running exercise, which closely simulates games-type activity, for comparison with continuous 
running exercise in type 1 diabetes patients. In conclusion, our data demonstrate that there is a 
lower risk of early-onset hypoglycaemia following intermittent running exercise that closely 
simulates team and games-play activity, than continuous running exercise. We postulate that the 
attenuation in blood glucose early (≤1 hour) after intermittent exercise is achieved by increases 
in counter-regulatory hormones and gluconeogenic substrates induced by this specific exercise 
modality. However, patients remain at risk from hypoglycaemia late after exercise irrelevant of 
the type of exercise performed. The declines in glycaemia during this time are suggested to be 
due to patients administering full or unchanged doses of rapid-acting insulin with their meal after 
exercise. We recommend future studies investigate manipulating the dose of rapid-acting insulin 
to be administered with the meal after intermittent running exercise. 
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Tables 
Table 1. The metabolic and hormonal responses to continuous versus simulated games type running exercise 
 Rest Exercise 0 5 15 30 60 Time Time*Condition 
Blood pH 
 
CON. 7.38±0.01  7.42±0.01† 7.43±0.01† 7.42±0.01† 7.42±0.01† 7.40±0.01 
p < 0.001 p < 0.001 
INT. 7.38±0.01  7.34±0.01*† 7.36±0.01* 7.39±0.01*† 7.40±0.01† 7.39±0.01 
Serum triglycerides 
(nmol.l-1) 
CON. 1.16±0.18  1.34±0.22† 1.26±0.20 1.15±0.17 1.09±0.18 1.06±0.23 
p = 0.001 p = 0.156 
INT. 1.23±0.24  1.35±0.27† 1.31±0.26 1.23±0.24 1.13±0.22 1.25±0.26 
Serum NEFA 
(mmol.l-1) 
CON. 0.31±0.06  0.21±0.05† 0.53±0.11 0.53±0.13 0.44±0.11 0.43±0.07 
p = 0.001 p = 0.092 
INT. 0.26±0.07  0.16±0.04† 0.40±0.10† 0.43±0.11 0.50±0.13 0.65±0.14 
Blood K+ 
(mmol.l-1) 
CON. 3.96±0.10  4.91±0.08† 4.24±0.08† 4.18±0.07† 4.10±0.09† 4.20±0.14 
p < 0.001 p < 0.001 
INT. 4.21±0.12  4.65±0.21† 3.83±0.15*† 4.10±0.13* 4.19±0.13 
 
4.51±0.19 
Blood Na++ 
(mmol.l-1) 
CON. 135±0.45  140±0.60† 140±0.57† 139±0.65† 138±0.73† 137±0.67† 
p < 0.001 p = 0.369 
INT. 134±0.98  139±1.16† 139±1.00† 138±0.91† 137±1.05† 135±1.31 
Serum cortisol 
(nmol.l-1) 
CON. 1.03±0.10  1.35±0.13 1.48±0.15 1.59±0.18† 1.28±0.13 1.18±0.17 
p < 0.002 p = 0.264 
INT. 1.34±0.26  1.99±0.26† 2.10±0.11† 2.10±0.11† 1.85±0.12† 1.60±0.14† 
NOTE: Data presented as mean ± SEM (n = 9). K+ = blood potassium, Na++ = blood sodium. * indicates a statistically significant difference between CON and INT. † indicates a statistically significant difference from 
Rest. Statistical significance accepted at p < 0.05. 
Figure legends 
(1) Data presented as mean ± SEM. Circles = CON, squares = INT. Transparent sample point within 
a condition indicates significance difference from resting concentrations (p <0.05). * indicates 
significantly different from CON (p <0.05). Thatched area indicates exercise. 
 
(2) Data presented as mean ± SEM. Circles = CON, squares = INT. Transparent sample point within 
a condition indicates significance difference from resting concentrations (p <0.05). * indicates 
significantly different from CON (p <0.05). Thatched area indicates exercise. 
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Figure 1. Time course changes in glycaemia from rest. 
 
 
 
 
 
 
 
 
 
 
Figure 2. Time course changes in blood lactate from rest. 
 
